世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035467

鉄剤の世界市場(2023-2027)

TechNavio

Global Iron Drugs Market 2023-2027

発刊日 2023/05/15

言語英語

体裁PDF/159ページ

ライセンス/価格159ページ

0000035467

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

鉄剤市場は、2022年から2027年の間に35億5,286万米ドル成長すると予測されており、予測期間中に9.41%のCAGRで加速します。鉄剤市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、世界的な鉄欠乏症の蔓延、全体的な健康維持における鉄の重要性に対する意識の高まり、および高齢者人口の増加によって牽引されています。

鉄剤市場は次のように分類されます。

  • 製品別
    ➣ 経口薬
    ➣ 点滴薬
  • 年齢層別
    ➣ 成人
    ➣ 小児
  • 地域別
    ➣ 北アメリカ
    ➣ ヨーロッパ
    ➣ アジア
    ➣ 世界のその他の地域

この調査は、新興経済国におけるCKD透析センターの数の増加が、今後数年間の鉄剤市場の成長を促進する主な理由の1つであることを特定しています。また、鉄剤に関する最近の開発の増加と、妊娠中の鉄サプリメントの使用の増加により、市場でのかなりの需要が見込まれるでしょう。

鉄剤市場に関するレポートは、次の分野をカバーしています。

  • 鉄剤市場の規模
  • 鉄剤市場の予測
  • 鉄剤市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、鉄剤市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ AbbVie Inc.
    ➣ Covis Pharma GmbH
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ GlaxoSmithKline Plc
    ➣ Hiral Labs Ltd.
    ➣ McKesson Corp.
    ➣ Pharmacosmos AS
    ➣ Procter and Gamble
    ➣ Reckitt Benckiser Group Plc
    ➣ Rockwell Medical Inc.
    ➣ Sanofi SA
    ➣ Shield Therapeutics plc
    ➣ Vifor Pharma Management Ltd.
    ➣ Zydus Lifesciences Ltd.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Age Group
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global iron drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global iron drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Age Group Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Age Group Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Oral drug - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral drug - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral drug - Year-over-year growth 2022-2027 (%)
6.4 IV drug - Market size and forecast 2022-2027
Exhibit 38: Chart on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on IV drug - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on IV drug - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Age Group
7.1 Market segments
Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)
7.2 Comparison by Age Group
Exhibit 46: Chart on Comparison by Age Group
Exhibit 47: Data Table on Comparison by Age Group
7.3 Adult - Market size and forecast 2022-2027
Exhibit 48: Chart on Adult - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Adult - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Adult - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Adult - Year-over-year growth 2022-2027 (%)
7.4 Pediatric - Market size and forecast 2022-2027
Exhibit 52: Chart on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Age Group
Exhibit 56: Market opportunity by Age Group ($ million)
Exhibit 57: Data Table on Market opportunity by Age Group ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Japan - Market size and forecast 2022-2027
Exhibit 83: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 95: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 112: AbbVie Inc. - Overview
Exhibit 113: AbbVie Inc. - Product / Service
Exhibit 114: AbbVie Inc. - Key news
Exhibit 115: AbbVie Inc. - Key offerings
12.5 Covis Pharma GmbH
Exhibit 116: Covis Pharma GmbH - Overview
Exhibit 117: Covis Pharma GmbH - Product / Service
Exhibit 118: Covis Pharma GmbH - Key offerings
12.6 Daiichi Sankyo Co. Ltd.
Exhibit 119: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 120: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 121: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 122: Daiichi Sankyo Co. Ltd. - Key offerings
12.7 GlaxoSmithKline Plc
Exhibit 123: GlaxoSmithKline Plc - Overview
Exhibit 124: GlaxoSmithKline Plc - Business segments
Exhibit 125: GlaxoSmithKline Plc - Key news
Exhibit 126: GlaxoSmithKline Plc - Key offerings
Exhibit 127: GlaxoSmithKline Plc - Segment focus
12.8 Hiral Labs Ltd.
Exhibit 128: Hiral Labs Ltd. - Overview
Exhibit 129: Hiral Labs Ltd. - Product / Service
Exhibit 130: Hiral Labs Ltd. - Key offerings
12.9 McKesson Corp.
Exhibit 131: McKesson Corp. - Overview
Exhibit 132: McKesson Corp. - Business segments
Exhibit 133: McKesson Corp. - Key offerings
Exhibit 134: McKesson Corp. - Segment focus
12.10 Pharmacosmos AS
Exhibit 135: Pharmacosmos AS - Overview
Exhibit 136: Pharmacosmos AS - Product / Service
Exhibit 137: Pharmacosmos AS - Key offerings
12.11 Procter and Gamble
Exhibit 138: Procter and Gamble - Overview
Exhibit 139: Procter and Gamble - Business segments
Exhibit 140: Procter and Gamble - Key offerings
Exhibit 141: Procter and Gamble - Segment focus
12.12 Reckitt Benckiser Group Plc
Exhibit 142: Reckitt Benckiser Group Plc - Overview
Exhibit 143: Reckitt Benckiser Group Plc - Business segments
Exhibit 144: Reckitt Benckiser Group Plc - Key offerings
Exhibit 145: Reckitt Benckiser Group Plc - Segment focus
12.13 Rockwell Medical Inc.
Exhibit 146: Rockwell Medical Inc. - Overview
Exhibit 147: Rockwell Medical Inc. - Product / Service
Exhibit 148: Rockwell Medical Inc. - Key offerings
12.14 Sanofi SA
Exhibit 149: Sanofi SA - Overview
Exhibit 150: Sanofi SA - Business segments
Exhibit 151: Sanofi SA - Key news
Exhibit 152: Sanofi SA - Key offerings
Exhibit 153: Sanofi SA - Segment focus
12.15 Shield Therapeutics plc
Exhibit 154: Shield Therapeutics plc - Overview
Exhibit 155: Shield Therapeutics plc - Product / Service
Exhibit 156: Shield Therapeutics plc - Key offerings
12.16 Vifor Pharma Management Ltd.
Exhibit 157: Vifor Pharma Management Ltd. - Overview
Exhibit 158: Vifor Pharma Management Ltd. - Product / Service
Exhibit 159: Vifor Pharma Management Ltd. - Key news
Exhibit 160: Vifor Pharma Management Ltd. - Key offerings
12.17 Zydus Lifesciences Ltd.
Exhibit 161: Zydus Lifesciences Ltd. - Overview
Exhibit 162: Zydus Lifesciences Ltd. - Business segments
Exhibit 163: Zydus Lifesciences Ltd. - Key offerings
Exhibit 164: Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global iron drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Age Group Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral drug - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral drug - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on IV drug - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on IV drug - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Age Group - Market share 2022-2027 (%)
Exhibits45: Data Table on Age Group - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Age Group
Exhibits47: Data Table on Comparison by Age Group
Exhibits48: Chart on Adult - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Adult - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Adult - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Adult - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Age Group ($ million)
Exhibits57: Data Table on Market opportunity by Age Group ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories - Overview
Exhibits108: Abbott Laboratories - Business segments
Exhibits109: Abbott Laboratories - Key news
Exhibits110: Abbott Laboratories - Key offerings
Exhibits111: Abbott Laboratories - Segment focus
Exhibits112: AbbVie Inc. - Overview
Exhibits113: AbbVie Inc. - Product / Service
Exhibits114: AbbVie Inc. - Key news
Exhibits115: AbbVie Inc. - Key offerings
Exhibits116: Covis Pharma GmbH - Overview
Exhibits117: Covis Pharma GmbH - Product / Service
Exhibits118: Covis Pharma GmbH - Key offerings
Exhibits119: Daiichi Sankyo Co. Ltd. - Overview
Exhibits120: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits121: Daiichi Sankyo Co. Ltd. - Key news
Exhibits122: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits123: GlaxoSmithKline Plc - Overview
Exhibits124: GlaxoSmithKline Plc - Business segments
Exhibits125: GlaxoSmithKline Plc - Key news
Exhibits126: GlaxoSmithKline Plc - Key offerings
Exhibits127: GlaxoSmithKline Plc - Segment focus
Exhibits128: Hiral Labs Ltd. - Overview
Exhibits129: Hiral Labs Ltd. - Product / Service
Exhibits130: Hiral Labs Ltd. - Key offerings
Exhibits131: McKesson Corp. - Overview
Exhibits132: McKesson Corp. - Business segments
Exhibits133: McKesson Corp. - Key offerings
Exhibits134: McKesson Corp. - Segment focus
Exhibits135: Pharmacosmos AS - Overview
Exhibits136: Pharmacosmos AS - Product / Service
Exhibits137: Pharmacosmos AS - Key offerings
Exhibits138: Procter and Gamble - Overview
Exhibits139: Procter and Gamble - Business segments
Exhibits140: Procter and Gamble - Key offerings
Exhibits141: Procter and Gamble - Segment focus
Exhibits142: Reckitt Benckiser Group Plc - Overview
Exhibits143: Reckitt Benckiser Group Plc - Business segments
Exhibits144: Reckitt Benckiser Group Plc - Key offerings
Exhibits145: Reckitt Benckiser Group Plc - Segment focus
Exhibits146: Rockwell Medical Inc. - Overview
Exhibits147: Rockwell Medical Inc. - Product / Service
Exhibits148: Rockwell Medical Inc. - Key offerings
Exhibits149: Sanofi SA - Overview
Exhibits150: Sanofi SA - Business segments
Exhibits151: Sanofi SA - Key news
Exhibits152: Sanofi SA - Key offerings
Exhibits153: Sanofi SA - Segment focus
Exhibits154: Shield Therapeutics plc - Overview
Exhibits155: Shield Therapeutics plc - Product / Service
Exhibits156: Shield Therapeutics plc - Key offerings
Exhibits157: Vifor Pharma Management Ltd. - Overview
Exhibits158: Vifor Pharma Management Ltd. - Product / Service
Exhibits159: Vifor Pharma Management Ltd. - Key news
Exhibits160: Vifor Pharma Management Ltd. - Key offerings
Exhibits161: Zydus Lifesciences Ltd. - Overview
Exhibits162: Zydus Lifesciences Ltd. - Business segments
Exhibits163: Zydus Lifesciences Ltd. - Key offerings
Exhibits164: Zydus Lifesciences Ltd. - Segment focus
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations

この商品のレポートナンバー

0000035467

TOP